Clinical trial

Study in Patients With COPD

NCT00215384

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Study timeline

Registry last updated2010-11-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

Interventions

Formoterol FumarateDRUG · verified · RxNorm: formoterol fumarate

Sponsors & collaborators

Deylead sponsor

Mapped research locations

Los AngelesCalifornia, United States1 DenverColorado, United States1 TacomaWashington, United States1 MedfordOregon, United States1 MissoulaMontana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00215384 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.